• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Lexicon Pharmaceuticals (LXRX)

Common Shares
Sell: $0.7055|Buy: $0.7299|Change: 0.01 (-0.86%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Address

8800 Technology Forest Place
The Woodlands
TX
USA
77381

Telephone

+1 281 8633000

Website

https://www.lexpharma.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Lexicon Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 20252026-03-06T17:00:00
Lexicon Pharmaceuticals Inc Fourth Quarter Earnings Results for 20252026-03-06T00:00:00
Lexicon Pharmaceuticals Inc Annual Report for 20252026-03-06T00:00:00
Lexicon Pharmaceuticals Inc Third Quarter Earnings Conference Call for 20252025-11-12T17:00:00
Lexicon Pharmaceuticals Inc Third Quarter Earnings Results for 20252025-11-12T00:00:00
Lexicon Pharmaceuticals Inc Second Quarter Earnings Conference Call for 20252025-08-01T17:00:00
Lexicon Pharmaceuticals Inc Second Quarter Earnings Results for 20252025-08-01T00:00:00
Lexicon Pharmaceuticals Inc Annual General Meeting for 20252025-05-09T08:00:00
Lexicon Pharmaceuticals Inc First Quarter Earnings Conference Call for 20252025-05-02T17:00:00
Lexicon Pharmaceuticals Inc First Quarter Earnings Results for 20252025-05-02T00:00:00

Previous key dates

NameKey Date
Lexicon Pharmaceuticals Inc Annual General Meeting for 20252025-05-09T08:00:00
Lexicon Pharmaceuticals Inc First Quarter Earnings Conference Call for 20252025-05-02T17:00:00
Lexicon Pharmaceuticals Inc First Quarter Earnings Results for 20252025-05-02T00:00:00
24th Annual Needham Virtual Healthcare Conference2025-04-09T08:00:00
Leerink Partners Global Healthcare Conference 20252025-03-12T10:00:00
Lexicon Pharmaceuticals Inc Annual Report for 20242025-03-07T00:00:00
Lexicon Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 20242025-03-06T17:00:00
Lexicon Pharmaceuticals Inc Fourth Quarter Earnings Results for 20242025-03-06T00:00:00
Lexicon Pharmaceuticals PROGRESS Topline Data Update2025-03-03T08:00:00
Lexicon Pharmaceuticals Business Update Call2024-11-22T09:00:00
Lexicon Pharmaceuticals to Participate in the Jefferies London Global Healthcare Conference2024-11-20T09:00:00
Lexicon Pharmaceuticals Inc Third Quarter Earnings Conference Call for 20242024-11-12T17:00:00
Lexicon Pharmaceuticals Inc Third Quarter Earnings Result for 20242024-11-12T00:00:00
2024 Cantor Fitzgerald Global Healthcare Conference2024-09-17T08:35:00
H.C. Wainwright 26th Annual Global Investment Conference2024-09-10T12:30:00
Lexicon Pharmaceuticals Inc Second Quarter Earnings Conference Call for 20242024-08-01T17:00:00
Lexicon Pharmaceuticals Inc Second Quarter Earnings Result for 20242024-08-01T00:00:00
Lexicon Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 20242024-06-05T15:00:00
Lexicon Pharmaceuticals Inc Annual General Meeting for 20242024-05-10T08:00:00
Lexicon Pharmaceuticals Inc First Quarter Earnings Conference Call for 20242024-05-02T17:00:00
Lexicon Pharmaceuticals Inc First Quarter Earnings Result for 20242024-05-02T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.